MétaCan
Menu
Back to cohort
Record W2529505662 · doi:10.1002/ccd.26802

First North American experience with the transfemoral ACURATE‐<i>neo</i><sup>TM</sup> self‐expanding transcatheter aortic bioprosthesis

2016· article· en· W2529505662 on OpenAlexafffund
Rodrigo Bagur, Patrick Teefy, Bob Kiaii, Pantelis Diamantouros, Michael Chu

Bibliographic record

VenueCatheterization and Cardiovascular Interventions · 2016
Typearticle
Languageen
FieldMedicine
TopicCardiac Valve Diseases and Treatments
Canadian institutionsLondon Health Sciences CentreWestern University
FundersSymetisLondon Health Sciences Centre
KeywordsMedicineStenosisCardiac skeletonCardiologyInternal medicineSurgeryAortic valve stenosisAortic valveAortic valve replacement

Abstract

fetched live from OpenAlex

Background: Transcatheter aortic valve implantation (TAVI) has become a therapeutic alternative for patients presenting with severe symptomatic aortic stenosis and considered at high‐surgical risk. Paravalvular leak (PVL), conduction disorders, and coronary obstruction remain unresolved procedure‐related complications. The aim of this manuscript was to report the first North American experience with the ACURATE‐ neo TM aortic bioprosthesis and its ACURATE‐TF TM delivery system (Symetis S.A., Ecublens, Switzerland). Methods: Transfemoral ACURATE‐ neo TM aortic valve implantation was performed in 20 patients. Clinical and echocardiographic assessment was performed at baseline, postprocedure and at least 30 days. Outcomes were assessed according to valvular academic research consortium (VARC‐2) criteria. Results: The mean age was 82.7 ± 7.0 years with a mean logistic‐EuroSCORE‐II of 5.0 ± 2.9% and Society of Thoracic Surgeons score of 4.7 ± 2.3%. Device success was achieved in all patients. The mean distance between the aortic‐annulus and the left main coronary artery ostium was 14.3 ± 3.2 mm, and eight (40%) patients had &lt;12 mm. At 30 days, there were no deaths, conversions to surgery, or major procedure‐related complications. New‐pacemaker implantation was required in one (5.3%) patient. ACURATE‐ neo TM implantation resulted in a significant reduction in mean transvalvular gradient (49.9 ± 15.8 to 9.7 ± 5.7 mm Hg, P &lt; 0.0001) and increase in effective‐orifice area (0.65 ± 0.16 to 1.83 ± 0.36 cm 2 , P = 0.001) at hospital discharge. Paravalvular leak was absent in four (20%) patients, trace in nine (45%) patients, and mild in seven (35%) patients. Hospital discharge occurred at a mean of 7.0 ± 4.5 days, and all patients were in NYHA class I–II at a mean follow‐up of 8.6 ± 2.3 months. Conclusion: The present initial North American experience shows that the ACURATE‐ neo TM aortic bioprosthesis was safely and successfully implanted by transfemoral approach. The special design of this newer‐generation device affords a stable and predictable implantation, while providing optimal hemodynamic performance with a relatively low rate of PPI. © 2016 Wiley Periodicals, Inc.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.282
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations24
Published2016
Admission routes2
Has abstractyes

Explore more

Same venueCatheterization and Cardiovascular InterventionsSame topicCardiac Valve Diseases and TreatmentsFrench-language works237,207